JP2008517918A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517918A5 JP2008517918A5 JP2007538033A JP2007538033A JP2008517918A5 JP 2008517918 A5 JP2008517918 A5 JP 2008517918A5 JP 2007538033 A JP2007538033 A JP 2007538033A JP 2007538033 A JP2007538033 A JP 2007538033A JP 2008517918 A5 JP2008517918 A5 JP 2008517918A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- immunogenic composition
- polypeptide
- staphylococcus epidermidis
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62078804P | 2004-10-21 | 2004-10-21 | |
| PCT/US2005/037746 WO2007001423A2 (en) | 2004-10-21 | 2005-10-19 | Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013021337A Division JP2013121981A (ja) | 2004-10-21 | 2013-02-06 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517918A JP2008517918A (ja) | 2008-05-29 |
| JP2008517918A5 true JP2008517918A5 (cg-RX-API-DMAC10.html) | 2008-10-02 |
Family
ID=37595601
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007538033A Pending JP2008517918A (ja) | 2004-10-21 | 2005-10-19 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物 |
| JP2013021337A Pending JP2013121981A (ja) | 2004-10-21 | 2013-02-06 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013021337A Pending JP2013121981A (ja) | 2004-10-21 | 2013-02-06 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓｅｐｉｄｅｒｍｉｄｉｓポリペプチド抗原の免疫原性組成物 |
Country Status (13)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2468803B (en) * | 2005-05-19 | 2011-01-19 | Exocyte Ltd | Screening methods for bacterial killing |
| EP2419129A2 (en) * | 2009-04-14 | 2012-02-22 | Novartis AG | Compositions for immunising against staphylococcus aerus |
| AU2010264538B2 (en) | 2009-06-22 | 2013-10-03 | Wyeth Llc | Immunogenic compositions of Staphylococcus aureus antigens |
| EP2473630B1 (en) * | 2009-09-04 | 2017-11-08 | QIAGEN GmbH | Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci |
| US9636410B2 (en) | 2011-07-06 | 2017-05-02 | Glaxosmithkline Biologicals Sa | Cationic oil-in-water emulsions |
| US9655845B2 (en) * | 2011-07-06 | 2017-05-23 | Glaxosmithkline Biologicals, S.A. | Oil-in-water emulsions that contain nucleic acids |
| EP2890387A1 (en) * | 2012-08-31 | 2015-07-08 | Novartis AG | Stabilised proteins for immunising against staphylococcus aureus |
| MX377794B (es) * | 2014-03-26 | 2025-03-10 | Glaxosmithkline Biologicals Sa | Antigenos estafilococicos mutantes. |
| JP7181208B2 (ja) * | 2016-10-21 | 2022-11-30 | ソクプラ、サイエンシズ、エ、ジェニ、エス．イー．シー． | ワクチン構築物およびブドウ球菌感染症に対するその使用 |
| SG11202106340XA (en) * | 2019-01-30 | 2021-07-29 | Fujifilm Electronic Materials Usa Inc | Container and method of preparing the same |
| KR102627009B1 (ko) * | 2021-12-17 | 2024-01-19 | (주)메디톡스 | 피부 유해 세균에 대한 항세균 활성을 갖는 세균 균주, 및 이를 포함하는 약제학적 조성물 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| DE3751873T2 (de) | 1986-04-09 | 1997-02-13 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
| ES2198405T3 (es) | 1991-11-22 | 2004-02-01 | Nabi Biopharmaceuticals | Antigenos de superficie de tipo i asociados a staphylococcus epidermis. |
| WO1993013302A1 (de) | 1991-12-23 | 1993-07-08 | Michael Zoche | Motor mit einer vorrichtung zur entölung |
| DE69329642T3 (de) * | 1992-03-19 | 2009-05-20 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren |
| ES2249760T3 (es) * | 1993-01-26 | 2006-04-01 | The Trustees Of The University Of Pennsylvania (A Corporation Of Pennsylvania) | Composiciones y procedimientos de administracion de materias geneticas. |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US6995008B1 (en) * | 1994-03-07 | 2006-02-07 | Merck & Co., Inc. | Coordinate in vivo gene expression |
| IL112820A0 (en) * | 1994-03-07 | 1995-05-26 | Merck & Co Inc | Coordinate in vivo gene expression |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| PT783520E (pt) * | 1994-09-21 | 2002-05-31 | Henry M Jackson Found Advanc M | Anticorpos opsonicos amplamente reactivos que reagem com antigenios de estafilococos comuns |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| WO1997014800A1 (en) * | 1995-10-16 | 1997-04-24 | Smithkline Beecham Plc | Novel saliva binding protein |
| US6168918B1 (en) | 1996-01-31 | 2001-01-02 | American Home Products Corp. | Method of detecting foreign DNA integrated in eukaryotic chromosomes |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US7060458B1 (en) | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| EP2330192A1 (en) | 1998-08-31 | 2011-06-08 | The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin | Polypeptides and polynucleotides from coagulase-negative staphylococci |
| JP4673974B2 (ja) | 1998-09-30 | 2011-04-20 | ワイス・ホールディングズ・コーポレイション | アジュバントとしての変異コレラホロトキシン |
| US6703492B1 (en) * | 1999-11-09 | 2004-03-09 | Smithkline Beecham Corporation | Staphylococcus epidermidis nucleic acids and proteins |
| AU1478301A (en) * | 1999-11-09 | 2001-06-06 | Glaxo Group Limited | Staphylococcus epidermidis nucleic acids and proteins |
| GB0014907D0 (en) | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| US20020169288A1 (en) * | 2001-03-15 | 2002-11-14 | Magnus Hook | Collagen-binding adhesin from staphylococcus epidermidis and method of use |
| US7332174B2 (en) | 2001-06-07 | 2008-02-19 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| WO2002098368A2 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| EP1412379B1 (en) | 2001-08-02 | 2012-01-25 | The University Of Sheffield | Vaccine |
| WO2004043405A2 (en) | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
| EP1603950A2 (en) | 2003-03-17 | 2005-12-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| AU2004226262A1 (en) * | 2003-03-31 | 2004-10-14 | Intercell Ag | Staphylococcus epidermidis antigens |
| ES2730275T3 (es) * | 2004-09-22 | 2019-11-11 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| PT2360255E (pt) | 2005-03-25 | 2015-04-08 | Nat Res Council Canada | Método para isolamento de polipéptidos solúveis |
-
2005
- 2005-10-19 BR BRPI0516974-7A patent/BRPI0516974A/pt not_active IP Right Cessation
- 2005-10-19 EP EP05858253A patent/EP1802335A2/en not_active Withdrawn
- 2005-10-19 TW TW094136450A patent/TW200619228A/zh unknown
- 2005-10-19 KR KR1020077011032A patent/KR20070068455A/ko not_active Withdrawn
- 2005-10-19 JP JP2007538033A patent/JP2008517918A/ja active Pending
- 2005-10-19 CN CNA2005800360186A patent/CN101175508A/zh active Pending
- 2005-10-19 CA CA002583121A patent/CA2583121A1/en not_active Abandoned
- 2005-10-19 WO PCT/US2005/037746 patent/WO2007001423A2/en not_active Ceased
- 2005-10-19 AU AU2005333603A patent/AU2005333603A1/en not_active Abandoned
- 2005-10-19 EP EP10182802A patent/EP2340848A3/en not_active Withdrawn
- 2005-10-19 EP EP09008910A patent/EP2213298A3/en not_active Withdrawn
- 2005-10-19 US US11/665,940 patent/US8445000B2/en not_active Expired - Fee Related
- 2005-10-19 EP EP10182797A patent/EP2298341A3/en not_active Withdrawn
- 2005-10-20 AR ARP050104384A patent/AR051826A1/es unknown
-
2007
- 2007-04-12 IL IL182546A patent/IL182546A0/en unknown
- 2007-04-20 ZA ZA200703274A patent/ZA200703274B/xx unknown
-
2013
- 2013-02-06 JP JP2013021337A patent/JP2013121981A/ja active Pending
- 2013-04-19 US US13/866,288 patent/US20130209501A1/en not_active Abandoned
-
2015
- 2015-03-31 US US14/674,512 patent/US20150196629A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5829830B2 (ja) | Ｅ型肝炎ウイルスのポリペプチド断片、それを含むワクチン組成物及び診断キット、並びにその使用 | |
| JP2004512022A5 (cg-RX-API-DMAC10.html) | ||
| JPH07504565A (ja) | ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質 | |
| JP2006525330A5 (cg-RX-API-DMAC10.html) | ||
| JP2009022296A (ja) | 髄膜炎菌種の細菌に特異的なｄｎａおよび蛋白質またはペプチド、それらの取得方法およびそれらの生物学的応用 | |
| JP2004507217A (ja) | リステリア菌ゲノム、ポリペプチドおよびその使用 | |
| JP2002508394A (ja) | 新規表面抗原 | |
| JP2019537424A5 (cg-RX-API-DMAC10.html) | ||
| EP0643770A1 (en) | Helicobacter pylori proteins useful for vaccines and diagnostics | |
| JP2010517544A5 (cg-RX-API-DMAC10.html) | ||
| Vaillancourt et al. | Identification and characterization of a new cell surface protein possessing factor H-binding activity in the swine pathogen and zoonotic agent Streptococcus suis | |
| US6808711B2 (en) | Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines | |
| Santona et al. | Mapping antigenic sites of an immunodominant surface lipoprotein of Mycoplasma agalactiae, AvgC, with the use of synthetic peptides | |
| CN111500586B (zh) | 特异结合狂犬病毒l蛋白加帽区的核酸适配体及其应用 | |
| US20100068214A1 (en) | Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus | |
| JP7230130B2 (ja) | マイコプラズマ・ヒオリニス感染を予防治療する組成物及びその活性成分を生産するための発現ベクター及び方法 | |
| TWI606839B (zh) | 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法 | |
| Bodjo et al. | Mapping and structural analysis of B-cell epitopes on the morbillivirus nucleoprotein amino terminus | |
| AU750792B2 (en) | 76 kDa, 32 kDa, and 50 kDa helicobacter polypeptides and corresponding polynucleotide molecules | |
| WO2015039271A1 (zh) | 蛋白a1g_01780在抗立氏立克次体的免疫保护中的应用 | |
| JP2008509659A5 (cg-RX-API-DMAC10.html) | ||
| CN103483430B (zh) | 蛋白a1g_07050在抗立氏立克次体的免疫保护中的应用 | |
| AU783201B2 (en) | DNA sequence encoding the specific antigen of salmonella typhi | |
| JP2003516136A (ja) | 肝炎ウイルスセンチネルウイルスｉ（ｓｖｉ） | |
| EP2908852B1 (en) | Lyme disease vaccine |